Oral immunotherapy for food allergy: Clinical and preclinical studies

Advanced Drug Delivery Reviews

Volumn 65, Issue 6, 2013, Pages 774-781

  Kulis, Mike ^a   Wesley Burks, A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Desensitization; Egg; Food allergy; Mice; Milk; Oral immunotherapy; Peanut; Tolerance

Indexed keywords

DESENSITIZATION; EGG; FOOD ALLERGIES; MICE; MILK; ORAL IMMUNOTHERAPY; PEANUT;

ALLERGENS; EXPERIMENTS; FITS AND TOLERANCES; MAMMALS; OILSEEDS;

ALLERGIES;

HERBACEOUS AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G4; IMMUNOLOGIC AGENT; IMMUNOMODULATING AGENT; OMALIZUMAB; PLACEBO; TALIZUMAB; TOLL LIKE RECEPTOR 9;

DESENSITIZATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EGG ALLERGY; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MAINTENANCE DRUG DOSE; MILK ALLERGY; NONHUMAN; ORAL IMMUNOTHERAPY; PEANUT ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; TREATMENT RESPONSE; UNITED STATES;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, ORAL; CLINICAL TRIALS AS TOPIC; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; EGG HYPERSENSITIVITY; FOOD HYPERSENSITIVITY; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; IMMUNOTHERAPY; MILK HYPERSENSITIVITY; PEANUT HYPERSENSITIVITY; PEDIATRICS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 84878867906     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.10.004     Document Type: Review

References (97)

1. Sicherer S.H., Sampson H.A. Food allergy: recent advances in pathophysiology and treatment. Annu. Rev. Med. 2009, 60:261-277.
2. Sicherer S.H., Sampson H.A. Food allergy. J. Allergy Clin. Immunol. 2010, 125:S116-S125.
3. Branum A.M., Lukacs S.L. Food allergy among children in the United States. Pediatrics 2009, 124:1549-1555.
4. Grundy J., Matthews S., Bateman B., Dean T., Arshad S.H. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J. Allergy Clin. Immunol. 2002, 110:784-789.
5. Sicherer S.H., Munoz-Furlong A., Sampson H.A. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J. Allergy Clin. Immunol. 2003, 112:1203-1207.
6. Venter C., Hasan Arshad S., Grundy J., Pereira B., Bernie Clayton C., Voigt K., Higgins B., Dean T. Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK. Allergy 2010, 65:103-108.
7. Sicherer S.H., Munoz-Furlong A., Godbold J.H., Sampson H.A. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J. Allergy Clin. Immunol. 2010, 125:1322-1326.
8. Vickery B.P., Scurlock A.M., Jones S.M., Burks A.W. Mechanisms of immune tolerance relevant to food allergy. J. Allergy Clin. Immunol. 2011, 127:576-584. (quiz 585-576).
9. Chehade M., Mayer L. Oral tolerance and its relation to food hypersensitivities. J. Allergy Clin. Immunol. 2005, 115:3-12. (quiz 13).
10. Akdis C.A. Allergy and hypersensitivity: mechanisms of allergic disease. Curr. Opin. Immunol. 2006, 18:718-726.
11. Osterfeld H., Ahrens R., Strait R., Finkelman F.D., Renauld J.C., Hogan S.P. Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis. J. Allergy Clin. Immunol. 2010, 125:469-476. (e462).
12. Boden S.R., Wesley Burks A. Anaphylaxis: a history with emphasis on food allergy. Immunol. Rev. 2011, 242:247-257.
13. Burks A.W. Peanut allergy. Lancet 2008, 371:1538-1546.
14. Clark S., Espinola J.A., Rudders S.A., Banerji A., Camargo C.A. Frequency of US emergency department visits for food-related acute allergic reactions. J. Allergy Clin. Immunol. 2011, 127:682-683.
15. Boyce J.A., Assa'ad A., Burks A.W., Jones S.M., Sampson H.A., Wood R.A., Plaut M., Cooper S.F., Fenton M.J., Arshad S.H., Bahna S.L., Beck L.A., Byrd-Bredbenner C., Camargo C.A., Eichenfield L., Furuta G.T., Hanifin J.M., Jones C., Kraft M., Levy B.D., Lieberman P., Luccioli S., McCall K.M., Schneider L.C., Simon R.A., Simons F.E., Teach S.J., Yawn B.P., Schwaninger J.M. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J. Allergy Clin. Immunol. 2010, 126:S1-S58.
16. Sicherer S.H., Noone S.A., Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann. Allergy Asthma Immunol. 2001, 87:461-464.
17. Savage J.H., Matsui E.C., Skripak J.M., Wood R.A. The natural history of egg allergy. J. Allergy Clin. Immunol. 2007, 120:1413-1417.
18. Skripak J.M., Matsui E.C., Mudd K., Wood R.A. The natural history of IgE-mediated cow's milk allergy. J. Allergy Clin. Immunol. 2007, 120:1172-1177.
19. Savage J.H., Limb S.L., Brereton N.H., Wood R.A. The natural history of peanut allergy: extending our knowledge beyond childhood. J. Allergy Clin. Immunol. 2007, 120:717-719.
20. Fleischer D.M., Conover-Walker M.K., Matsui E.C., Wood R.A. The natural history of tree nut allergy. J. Allergy Clin. Immunol. 2005, 116:1087-1093.
21. Bock S.A., Munoz-Furlong A., Sampson H.A. Fatalities due to anaphylactic reactions to foods. J. Allergy Clin. Immunol. 2001, 107:191-193.
22. Bock S.A., Munoz-Furlong A., Sampson H.A. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J. Allergy Clin. Immunol. 2007, 119:1016-1018.
23. Fleischer D.M. The natural history of peanut and tree nut allergy. Curr. Allergy Asthma Rep. 2007, 7:175-181.
24. Shreffler W.G., Wanich N., Moloney M., Nowak-Wegrzyn A., Sampson H.A. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J. Allergy Clin. Immunol. 2009, 123:43-52. (e47).
25. Savilahti E.M., Rantanen V., Lin J.S., Karinen S., Saarinen K.M., Goldis M., Makela M.J., Hautaniemi S., Savilahti E., Sampson H.A. Early recovery from cow's milk allergy is associated with decreasing IgE and increasing IgG4 binding to cow's milk epitopes. J. Allergy Clin. Immunol. 2010, 125:1315-1321. (e1319).
26. Wang J., Lin J., Bardina L., Goldis M., Nowak-Wegrzyn A., Shreffler W.G., Sampson H.A. Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy. J. Allergy Clin. Immunol. 2010, 125:695-702. (702 e691-702 e696).
27. Wanich N., Nowak-Wegrzyn A., Sampson H.A., Shreffler W.G. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J. Allergy Clin. Immunol. 2009, 123:789-794. (e720).
28. Jarvinen K.M., Beyer K., Vila L., Bardina L., Mishoe M., Sampson H.A. Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy. Allergy 2007, 62:758-765.
29. Vila L., Beyer K., Jarvinen K.M., Chatchatee P., Bardina L., Sampson H.A. Role of conformational and linear epitopes in the achievement of tolerance in cow's milk allergy. Clin. Exp. Allergy 2001, 31:1599-1606.
30. Shreffler W.G., Beyer K., Chu T.H., Burks A.W., Sampson H.A. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J. Allergy Clin. Immunol. 2004, 113:776-782.
31. Shreffler W.G., Lencer D.A., Bardina L., Sampson H.A. IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J. Allergy Clin. Immunol. 2005, 116:893-899.
32. Lin J., Bruni F.M., Fu Z., Maloney J., Bardina L., Boner A.L., Gimenez G., Sampson H.A. A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay. J. Allergy Clin. Immunol. 2012, 129:1321-1328.
33. Caubet J.C., Bencharitiwong R., Moshier E., Godbold J.H., Sampson H.A., Nowak-Wegrzyn A. Significance of ovomucoid- and ovalbumin-specific IgE/IgG(4) ratios in egg allergy. J. Allergy Clin. Immunol. 2012, 129:739-747.
34. Sicherer S.H., Wood R.A., Stablein D., Burks A.W., Liu A.H., Jones S.M., Fleischer D.M., Leung D.Y., Grishin A., Mayer L., Shreffler W., Lindblad R., Sampson H.A. Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J. Allergy Clin. Immunol. 2010, 125:1077-1083. (e1078).
35. Akdis C.A., Akdis M. Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 2011, 127:18-27. (quiz 28-19).
36. Oppenheimer J.J., Nelson H.S., Bock S.A., Christensen F., Leung D.Y. Treatment of peanut allergy with rush immunotherapy. J. Allergy Clin. Immunol. 1992, 90:256-262.
37. Nucera E., Schiavino D., D'Ambrosio C., Stabile A., Rumi C., Gasbarrini G., Patriarca G. Immunological aspects of oral desensitization in food allergy. Dig. Dis. Sci. 2000, 45:637-641.
38. Patriarca G., Nucera E., Roncallo C., Pollastrini E., Bartolozzi F., De Pasquale T., Buonomo A., Gasbarrini G., Di Campli C., Schiavino D. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment. Pharmacol. Ther. 2003, 17:459-465.
39. Patriarca G., Schiavino D., Nucera E., Schinco G., Milani A., Gasbarrini G.B. Food allergy in children: results of a standardized protocol for oral desensitization. Hepatogastroenterology 1998, 45:52-58.
40. Jones S.M., Pons L., Roberts J.L., Scurlock A.M., Perry T.T., Kulis M., Shreffler W.G., Steele P., Henry K.A., Adair M., Francis J.M., Durham S., Vickery B.P., Zhong X., Burks A.W. Clinical efficacy and immune regulation with peanut oral immunotherapy. J. Allergy Clin. Immunol. 2009, 124:292-300. (300 e291-297).
41. Hofmann A.M., Scurlock A.M., Jones S.M., Palmer K.P., Lokhnygina Y., Steele P.H., Kamilaris J., Burks A.W. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J. Allergy Clin. Immunol. 2009, 124:286-291. (291 e281-286).
42. Shamji M.H., Wilcock L.K., Wachholz P.A., Dearman R.J., Kimber I., Wurtzen P.A., Larche M., Durham S.R., Francis J.N. The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. J. Immunol. Methods 2006, 317:71-79.
43. Shreffler W.G. Evaluation of basophil activation in food allergy: present and future applications. Curr. Opin. Allergy Clin. Immunol. 2006, 6:226-233.
44. Varshney P., Jones S.M., Scurlock A.M., Perry T.T., Kemper A., Steele P., Hiegel A., Kamilaris J., Carlisle S., Yue X., Kulis M., Pons L., Vickery B., Burks A.W. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J. Allergy Clin. Immunol. 2011, 127:654-660.
45. Thyagarajan A., Jones S.M., Calatroni A., Pons L., Kulis M., Woo C.S., Kamalakannan M., Vickery B.P., Scurlock A.M., Wesley Burks A., Shreffler W.G. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin. Exp. Allergy 2012, 42:1197-1205.
46. Blumchen K., Ulbricht H., Staden U., Dobberstein K., Beschorner J., de Oliveira L.C., Shreffler W.G., Sampson H.A., Niggemann B., Wahn U., Beyer K. Oral peanut immunotherapy in children with peanut anaphylaxis. J. Allergy Clin. Immunol. 2010, 126:83-91. (e81).
47. Anagnostou K., Clark A., King Y., Islam S., Deighton J., Ewan P. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin. Exp. Allergy 2011, 41:1273-1281.
48. Clark A.T., Islam S., King Y., Deighton J., Anagnostou K., Ewan P.W. Successful oral tolerance induction in severe peanut allergy. Allergy 2009, 64:1218-1220.
49. Skripak J.M., Nash S.D., Rowley H., Brereton N.H., Oh S., Hamilton R.G., Matsui E.C., Burks A.W., Wood R.A. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J. Allergy Clin. Immunol. 2008, 122:1154-1160.
50. Keet C.A., Frischmeyer-Guerrerio P.A., Thyagarajan A., Schroeder J.T., Hamilton R.G., Boden S., Steele P., Driggers S., Burks A.W., Wood R.A. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J. Allergy Clin. Immunol. 2012, 129:448-455. (e445).
51. Kim E.H., Bird J.A., Kulis M., Laubach S., Pons L., Shreffler W., Steele P., Kamilaris J., Vickery B., Burks A.W. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J. Allergy Clin. Immunol. 2011, 127:640-646. (e641).
52. Chin S.J., Kim E.H., Kulis M.D., Varshney P., Steele P., Kamilaris J., Hiegel A., Carlisle S., Scurlock A.M., Smith P.B., Vickery B.P., Jones S.M., Burks A.W. Comparison of sublingual immunotherapy (SLIT) versus oral immunotherapy in the treatment of peanut allergy. J. Allergy Clin. Immunol. 2012, 129:AB140.
53. Nowak-Wegrzyn A., Bloom K.A., Sicherer S.H., Shreffler W.G., Noone S., Wanich N., Sampson H.A. Tolerance to extensively heated milk in children with cow's milk allergy. J. Allergy Clin. Immunol. 2008, 122:342-347. (347 e341-342).
54. Kim J.S., Nowak-Wegrzyn A., Sicherer S.H., Noone S., Moshier E.L., Sampson H.A. Dietary baked milk accelerates the resolution of cow's milk allergy in children. J. Allergy Clin. Immunol. 2011, 128:125-131. (e122).
55. Buchanan A.D., Green T.D., Jones S.M., Scurlock A.M., Christie L., Althage K.A., Steele P.H., Pons L., Helm R.M., Lee L.A., Burks A.W. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J. Allergy Clin. Immunol. 2007, 119:199-205.
56. Vickery B.P., Pons L., Kulis M., Steele P., Jones S.M., Burks A.W. Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann. Allergy Asthma Immunol. 2010, 105:444-450.
57. Burks A.W., Jones S.M., Wood R.A., Fleischer D.M., Sicherer S.H., Lindblad R.W., Stablein D., Henning A.K., Vickery B.P., Liu A.H., Scurlock A.M., Shreffler W.G., Plaut M., Sampson H.A. Oral immunotherapy for treatment of egg allergy in children. N. Engl. J. Med. 2012, 367:233-243.
58. Jones S.M., Burks A.W., Wood R.A., Fleischer D.M., Sicherer S.H., Lindblad R., Stablein D., Henning A.K., Vickery B.P., Liu A.H., Scurlock A.M., Shreffler W., Plaut M., Sampson H.A. A randomized, double-blind, placebo-controlled, multicenter trial of egg oral immunotherapy in children: an analysis of clinical tolerance. J. Allergy Clin. Immunol. 2012, 129.
59. Martos G., Lopez-Exposito I., Bencharitiwong R., Berin M.C., Nowak-Wegrzyn A. Mechanisms underlying differential food allergy response to heated egg. J. Allergy Clin. Immunol. 2011, 127:990-997. (e991-992).
60. Lemon-Mule H., Sampson H.A., Sicherer S.H., Shreffler W.G., Noone S., Nowak-Wegrzyn A. Immunologic changes in children with egg allergy ingesting extensively heated egg. J. Allergy Clin. Immunol. 2008, 122:977-983. (e971).
61. Leung D.Y., Sampson H.A., Yunginger J.W., Burks A.W., Schneider L.C., Wortel C.H., Davis F.M., Hyun J.D., Shanahan W.R. Effect of anti-IgE therapy in patients with peanut allergy. N. Engl. J. Med. 2003, 348:986-993.
62. Sampson H.A., Leung D.Y., Burks A.W., Lack G., Bahna S.L., Jones S.M., Wong D.A. A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J. Allergy Clin. Immunol. 2011, 127:1309-1310. (e1301).
63. Pons L., Palmer K., Burks W. Towards immunotherapy for peanut allergy. Curr. Opin. Allergy Clin. Immunol. 2005, 5:558-562.
64. Casale T.B., Busse W.W., Kline J.N., Ballas Z.K., Moss M.H., Townley R.G., Mokhtarani M., Seyfert-Margolis V., Asare A., Bateman K., Deniz Y. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J. Allergy Clin. Immunol. 2006, 117:134-140.
65. Nadeau K.C., Schneider L.C., Hoyte L., Borras I., Umetsu D.T. Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J. Allergy Clin. Immunol. 2011, 127:1622-1624.
66. Henson M., Edie A., Steele P., Kamilaris J., Kulis M., Thyagarajan A., Vickery B.P., Burks A.W. Peanut oral immunotherapy and omalizumab treatment for peanut allergy. J. Allergy Clin. Immunol. 2012, 129.
67. Burks A.W., Vickery B.P., Scurlock A.M., Steele P., Kamilaris J., Hiegel A., Carlisle S., Perry T.T., Jones S.M. Development of clinical tolerance after peanut OIT. J. Allergy Clin. Immunol. 2012, 129.
68. Li X.M., Serebrisky D., Lee S.Y., Huang C.K., Bardina L., Schofield B.H., Stanley J.S., Burks A.W., Bannon G.A., Sampson H.A. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J. Allergy Clin. Immunol. 2000, 106:150-158.
69. Khodoun M., Strait R., Orekov T., Hogan S., Karasuyama H., Herbert D.R., Kohl J., Finkelman F.D. Peanuts can contribute to anaphylactic shock by activating complement. J. Allergy Clin. Immunol. 2009, 123:342-351.
70. Berin C., Wang W. Oral immunotherapy in the sensitized mouse: barriers to tolerance induction. J. Allergy Clin. Immunol. 2010, 125.
71. Leonard S.A., Martos G., Lopez-Exposito I., Wang W., Nowak-Wegryzn A., Berin C. Oral immunotherapy in a murine model of food allergy induces desensitization with high dose antigen and heated or native antigen. J. Allergy Clin. Immunol. 2011, 127.
72. Zhu F.G., Kandimalla E.R., Yu D., Agrawal S. Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice. J. Allergy Clin. Immunol. 2007, 120:631-637.
73. Creticos P.S., Schroeder J.T., Hamilton R.G., Balcer-Whaley S.L., Khattignavong A.P., Lindblad R., Li H., Coffman R., Seyfert V., Eiden J.J., Broide D. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 2006, 355:1445-1455.
74. Larche M. Immunotherapy with allergen peptides. Allergy Asthma Clin. Immunol. 2007, 3:53-59.
75. Yang M., Yang C., Mine Y. Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor-beta-associated mechanisms. Clin. Exp. Allergy 2010, 40:668-678.
76. Rupa P., Mine Y. Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy. Allergy 2012, 67:74-82.
77. Prickett S.R., Voskamp A.L., Dacumos-Hill A., Symons K., Rolland J.M., O'Hehir R.E. Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a peanut allergy therapeutic. J. Allergy Clin. Immunol. 2011, 127:608-615. (e601-605).
78. Burggraf M., Nakajima-Adachi H., Hachimura S., Ilchmann A., Pemberton A.D., Kiyono H., Vieths S., Toda M. Oral tolerance induction does not resolve gastrointestinal inflammation in a mouse model of food allergy. Mol. Nutr. Food Res. 2011, 55:1475-1483.
79. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 1999, 5:387-391.
80. Srivastava K.D., Kattan J.D., Zou Z.M., Li J.H., Zhang L., Wallenstein S., Goldfarb J., Sampson H.A., Li X.M. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J. Allergy Clin. Immunol. 2005, 115:171-178.
81. Qu C., Srivastava K., Ko J., Zhang T.F., Sampson H.A., Li X.M. Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma. Clin. Exp. Allergy 2007, 37:846-855.
82. Srivastava K.D., Sampson H.A., Li X. The traditional Chinese medicine formula FAHF-2 provides complete protection from anaphylaxis in a murine model of multiple food allergy. J. Allergy Clin. Immunol. 2009, 123.
83. Srivastava K.D., Qu C., Zhang T., Goldfarb J., Sampson H.A., Li X.M. Food allergy herbal formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells. J. Allergy Clin. Immunol. 2009, 123:443-451.
84. Song Y., Qu C., Srivastava K., Yang N., Busse P., Zhao W., Li X.M. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils. J. Allergy Clin. Immunol. 2010, 126:1208-1217. (e1203).
85. Wang J., Patil S.P., Yang N., Ko J., Lee J., Noone S., Sampson H.A., Li X.M. Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study. Ann. Allergy Asthma Immunol. 2010, 105:75-84.
86. Patil S.P., Wang J., Song Y., Noone S., Yang N., Wallenstein S., Sampson H.A., Li X.M. Clinical safety of food allergy herbal formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study. J. Allergy Clin. Immunol. 2011, 128:1259-1265. (e1252).
87. Pons L., Ponnappan U., Hall R.A., Simpson P., Cockrell G., West C.M., Sampson H.A., Helm R.M., Burks A.W. Soy immunotherapy for peanut-allergic mice: modulation of the peanut-allergic response. J. Allergy Clin. Immunol. 2004, 114:915-921.
88. Masilamani M., Wei J., Bhatt S., Paul M., Yakir S., Sampson H.A. Soybean isoflavones regulate dendritic cell function and suppress allergic sensitization to peanut. J. Allergy Clin. Immunol. 2011, 128:1242-1250. (e1241).
89. Kulis M., Li Y., Lane H., Pons L., Burks W. Single-tree nut immunotherapy attenuates allergic reactions in mice with hypersensitivity to multiple tree nuts. J. Allergy Clin. Immunol. 2011, 127:81-88.
90. Kulis M., Chen X., Lew J., Wang Q., Patel O.P., Zhuang Y., Murray K.S., Duncan M.W., Porterfield H.S., Burks A.W., Dreskin S.C. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice. Clin. Exp. Allergy 2012, 42:326-336.
91. Porterfield H.S., Murray K.S., Schlichting D.G., Chen X., Hansen K.C., Duncan M.W., Dreskin S.C. Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants. Clin. Exp. Allergy 2009, 39:1099-1108.
92. Flinterman A.E., van Hoffen E., den Hartog Jager C.F., Koppelman S., Pasmans S.G., Hoekstra M.O., Bruijnzeel-Koomen C.A., Knulst A.C., Knol E.F. Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time. Clin. Exp. Allergy 2007, 37:1221-1228.
93. Nicolaou N., Poorafshar M., Murray C., Simpson A., Winell H., Kerry G., Harlin A., Woodcock A., Ahlstedt S., Custovic A. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J. Allergy Clin. Immunol. 2010, 125:191-197. (e191-113).
94. Dang T.D., Tang M., Choo S., Licciardi P.V., Koplin J.J., Martin P.E., Tan T., Gurrin L.C., Ponsonby A.L., Tey D., Robinson M., Dharmage S.C., Allen K.J. Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. J. Allergy Clin. Immunol. 2012, 129:1056-1063.
95. DeLong J.H., Simpson K.H., Wambre E., James E.A., Robinson D., Kwok W.W. Ara h 1-reactive T cells in individuals with peanut allergy. J. Allergy Clin. Immunol. 2011, 127:1211-1218. (e1213).
96. Durham S.R., Leung D.Y. One hundred years of allergen immunotherapy: time to ring the changes. J. Allergy Clin. Immunol. 2011, 127:3-7.
97. Thyagarajan A., Varshney P., Jones S.M., Sicherer S., Wood R., Vickery B.P., Sampson H., Burks A.W. Peanut oral immunotherapy is not ready for clinical use. J. Allergy Clin. Immunol. 2010, 126:31-32.